I would like to start a regular segment where I explain the latest findings for therapists!For our momentous first ...

A tiny region deep within the brain has surprised scientists by revealing a remarkably sophisticated communication system.

On October 7, 2026, Cerevance announced the top-line results of the Phase 3 ARISE trial for the investigational Parkinson's ...

A conductance-based computer model of the Parkinsonian brain circuit shows that deep brain stimulation and rhythmic visual ...

A study of 173 residents in Lhasa finds that serum uric acid mediates the link between poor altitude adaptation and disrupted ...

Stuttering is a common speech disorder that can affect people’s lives in many ways. The Stuttering Treatment and Research ...

There is no clear cause of schizophrenia, but several risk factors may interact to cause a predisposition to schizophrenia. Some changes in brain neurotransmitter activity and brain pathways are ...

Source: Sara Sherman, used with permission We were listening to a classic Sinatra record the other day—"Fly Me to the Moon"—and caught our feet tapping long before we even realized the music had ...

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel “for discoveries leading to ...

The novel GPR6 inhibitor met its primary endpoint in the phase 3 ARISE trial, achieving a statistically significant reduction in daily OFF time and demonstrating non-dopaminergic motor and ...

From Parkinson’s disease to palliative care, music therapy is showing benefits across 10 clinical settings, though the ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.